![](https://media.beehiiv.com/cdn-cgi/image/fit=scale-down,format=auto,onerror=redirect,quality=80/uploads/asset/file/1022e75f-9694-451c-95ba-14ec0069c5e9/image__1_.png)
Good day, 360 –
Happy Veteran’s Day today 🇺🇸, we don’t say it enough but we are truly grateful for your service. And to celebrate this day, we have ten complimentary passes available for two-week access to any of our trading services, with no credit card required, etc. Just contact Jeff Brown 1–800-585-4488/ [email protected]!
FOCUS LIST🔎
TCON – Up over 100% in pre-market after reporting better than expected earnings
MRAI – Up over 80% in pre after filing to withdraw its stock offering
DRCT – Up over 50% in pre after reporting better than expected earnings
SPOTLIGHT💡
“Lunch 🥪 with Jeff”
You are invited to come learn about options and watch me trade live this afternoon, all at no cost.
![](https://media.beehiiv.com/cdn-cgi/image/fit=scale-down,format=auto,onerror=redirect,quality=80/uploads/asset/file/639a77d5-c11a-4620-91af-3a38884013e0/zUwx6XGQpSUlppFpFyUd5axFTzAaZNu3J-txZBvgEF7D2D5ZnLimUQFHfLfqAGk2pnguw1ewIr0PYTxDV2app1dW5PeZMjMznHpuk6Xau-FjhRCDxTI0B1ZbZcbmjRZzzaLKfUrvNwwjGL71G4w7kbA.png)
Bring your lunch, and your trading questions, and come join me for an exciting trading session today at 12pm EST.
And I’m starting a Trading Challenge for new Alpha Hunter members with this AMAZING guarantee:
HOTLIST🔥
TCON – Up over 100% in pre-market after reporting better than expected earnings
TRACON Pharmaceuticals (TCON) is a biopharmaceutical company that focuses on the development and commercialization of novel targeted therapeutics for cancer in the United States.
Yesterday, in the afterhours TCON reported Q3 earnings of $0.29 vs -$0.30 a year prior. THis represents a 196.67% year over year increase.
In addition, this morning it was reported that H.C. Wainwright reiterated its Buy rating on TCON and gave it a $7 price target.
The stock is trading up over 100% in pre-market around $0.32 this morning.
![](https://media.beehiiv.com/cdn-cgi/image/fit=scale-down,format=auto,onerror=redirect,quality=80/uploads/asset/file/ef2cc57e-1469-4546-bd50-348f5b6944f6/TCON111023.png)
The $0.35 area was support in the pre-market and now becomes a level of potential resistance.
Above it, targets to the upside are $0.37 and $0.40 with the pre-market high of $0.4350 above that. Beyond that, $0.50, $0.60, $0.70 and $0.80 come into play.
Below $0.35, there is potential support at $0.3150, $0.30, $0.27, $0.20 and then a gap to fill at $0.16.
MRAI – Up over 80% in pre after filing to withdraw its stock offering
Marpai, Inc (MRAI) is a technology-driven healthcare payer that focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, bill review and cost containment services. It also develops artificial intelligence and healthcare technology.
By doing this, it is withdrawing its stock offering, meaning its less likely for the company to issue more stock and dilute existing shareholders which could be weighing on the stock price.
The stock is up over 80% in pre-market after the filing.
![](https://media.beehiiv.com/cdn-cgi/image/fit=scale-down,format=auto,onerror=redirect,quality=80/uploads/asset/file/373ae8ed-e5a3-43d4-bc6a-d0a8dc61d040/pasted_image_0.png)
$0.70 was an area of resistance in the after-hours and now becomes a potential level of support.
Above it, targets to the upside are $0.80, $0.85 and then the pre-market high at $1.02. Beyond that, $1.50 and $2 come into play.
Below $0.70, there is potential support at $0.63, $0.60 and then a gap to fill at $0.3787.
DRCT – Up over 50% in pre after reporting better than expected earnings
Direct Digital Holdings (DRCT) operates as an end-to-end full-service programmatic advertising platform. The company’s platform primarily focuses on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy- and sell-side of the digital advertising ecosystem.
In the after-hours yesterday, DRCT reported Q3 2023 EPS of $0.23 vs $0.05 expected, on revenue of $59.47million vs $34.48 expected. The company also guided that it sees full year 2023 revenue of $170million-$190million vs the $127.98million estimate.The earnings estimate beat expectation by 360% and the full year guidance is 50% above estimates.
The stock traded over 50% higher in pre-market after the news.
![](https://media.beehiiv.com/cdn-cgi/image/fit=scale-down,format=auto,onerror=redirect,quality=80/uploads/asset/file/434c5f65-0076-4a4d-932f-441603c549e2/DRCT111023.png)
The $3.60 level acted as resistance in the after-hours and pre-market before DRCT broke higher, and it now is a potential area of support.
Above it, targets to the upside are $4 and then the pre-market high at $4.12. Beyond that, $4.50, $5 and $6 come into play.
Below $3.60, there is potential support at $3.40, $3.20, $3 and then a gap fill at $2.61.
MARKET NEWS
![](https://media.beehiiv.com/cdn-cgi/image/fit=scale-down,format=auto,onerror=redirect,quality=80/uploads/asset/file/f280de97-5e6d-482b-a9d1-9d19bfad2690/Econ101123.png)
Questions or concerns about our products? Email [email protected] © Copyright 2022, RagingBull
DISCLAIMER To more fully understand any Ragingbull.com, LLC (“RagingBull”) subscription, website, application or other service (“Services”), please review our full disclaimer located at https://ragingbull.com/disclaimer
FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision.
RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers’ trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.
RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers.
RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled.
WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.